Welcome to Acute Condition!
Telehealth is commoditized
Remote patient monitoring, which has a lot of promise, has hardly progressed farther than consumer wearables
The potential primary care implications of those consumer wearables remains locked
Digital therapeutics are being priced and prescribed like traditional pharmaceuticals, putting a financial moat around them
CMS has provoked some rearranging of the traditional model (which is, as of early 2022, being reworked)—although full expression of value-based care remains locked by traditional challenges and, in some cases, not-yet-scalable science and computing power
At the same time, supply and demand constraints have forced the beginnings of some new models to appear
It remains to be seen if the development of new, innovative models requires going around the traditional system or going through it